The Effect of Edaravone on Respiratory Function in Amyotrophic Lateral Sclerosis (ALS)

被引：0
|
作者：
McGrath, C. [1 ]
File, B. [2 ]
Guarnieri, J. [3 ]
Houseman, G. [3 ]
Oakley, L. [3 ]
Pasinelli, P. [3 ]
Ackrivo, J. [4 ]
West, F. M. [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Jane & Leonard Korman Resp Inst, Philadelphia, PA 19107 USA
[2] Sidney Kimmel Med Coll, Philadelphia, PA USA
[3] Thomas Jefferson Univ Hosp, Weinberg ALS Ctr, Philadelphia, PA 19107 USA
[4] Hosp Univ Penn, Pulm Allergy & Crit Care Div, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3259
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Respiratory Function Changes as Early Signs of Amyotrophic Lateral Sclerosis
    Polverino, Mario
    Sampaolo, Simone
    Capuozzo, Antonio
    Fasolino, Marco
    Aliberti, Michele
    Satta, Ersilia
    Santoriello, Carlo
    Orengo, James Peter
    Polverino, Francesca
    RESPIRATION, 2023, 102 (11) : 919 - 923
  • [42] Lung function and respiratory muscle strength in amyotrophic lateral sclerosis
    Sandnes, Astrid
    Andersen, Tiina
    Vollsaeter, Maria
    Fondenes, Ove
    Roksund, Ola
    Halvorsen, Thomas
    Clemm, Hege
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [43] Levosimendan fails to improve respiratory function in amyotrophic lateral sclerosis
    Wood H.
    Nature Reviews Neurology, 2021, 17 (11) : 660 - 660
  • [44] The progression of amyotrophic lateral sclerosis: respiratory function - Authors' reply
    Salord, N
    Miralda, RM
    Casan, P
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (07): : 328 - 328
  • [45] Respiratory muscle function in patients with amyotrophic lateral sclerosis.
    Ramonatxo, M
    Fabre, C
    Hayot, M
    Camu, W
    Billiard, M
    Préfaut, C
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A261 - A261
  • [46] Familial amyotrophic lateral sclerosis (FALS) presenting as primary lateral sclerosis (PLS) and classical amyotrophic lateral sclerosis (ALS)
    Mezei, MM
    Stewart, HG
    Andersen, PM
    Eisen, AE
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S2 - S2
  • [47] Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics
    Breiner, Ari
    Zinman, Lorne
    Bourque, Pierre R.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (12) : E319 - E320
  • [48] Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS) Protocol and Study Design
    Berry, James
    Brooks, Benjamin
    Genge, Angela
    Heiman-Patterson, Terry
    Appel, Stanley
    Benatar, Michael
    Bowser, Robert
    Cudkowicz, Merit
    Gooch, Clifton
    Shefner, Jeremy
    Westra, Jurjen
    Agnese, Wendy
    Merrill, Charlotte
    Nelson, Sally
    Apple, Stephen
    NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (04) : E472 - E479
  • [49] Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
    Cho, HaEun
    Shukla, Surabhi
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 14
  • [50] Critical issues in the use of edaravone for the treatment of amyotrophic lateral sclerosis
    Seok, Hung Youl
    NEUROLOGICAL SCIENCES, 2025,
12345